Skip to content
10-Q

Quarterly Report

RESHAPE LIFESCIENCES INC.

0001558370-21-007416

← back to feed
Filed
May 17, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · May 14, 2021 6.17M sh
Operating Cash Flow Q1 2021 · Mar 31, 2021 −$1.96M
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$3.25M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $896K
Cash And Equivalents Q1 2021 · Dec 31, 2020 $2.96M
Stockholders Equity Q1 2021 · Mar 31, 2021 $12.71M
Stockholders Equity Q1 2021 · Dec 31, 2020 $14.49M
Stockholders Equity Q1 2021 · Mar 31, 2020 $21.57M
Stockholders Equity Q1 2021 · Dec 31, 2019 $24.11M
Current Liabilities Q1 2021 · Mar 31, 2021 $21.63M
Current Liabilities Q1 2021 · Dec 31, 2020 $11.61M
Total Liabilities Q1 2021 · Mar 31, 2021 $23.31M
Total Liabilities Q1 2021 · Dec 31, 2020 $22.57M
Current Assets Q1 2021 · Mar 31, 2021 $8.25M
Current Assets Q1 2021 · Dec 31, 2020 $8.94M
Total Assets Q1 2021 · Mar 31, 2021 $36.02M
Total Assets Q1 2021 · Dec 31, 2020 $37.06M
Sga Expense Q1 2021 · Mar 31, 2021 $1.25M
Sga Expense Q1 2021 · Mar 31, 2020 $1.45M
Rd Expense Q1 2021 · Mar 31, 2021 $571K
Rd Expense Q1 2021 · Mar 31, 2020 $1.3M
Net Income Q1 2021 · Mar 31, 2021 −$4.87M
Net Income Q1 2021 · Mar 31, 2020 −$4.31M
Operating Income Q1 2021 · Mar 31, 2021 −$2.26M
Operating Income Q1 2021 · Mar 31, 2020 −$4.08M
Gross Profit Q1 2021 · Mar 31, 2021 $2.28M
Gross Profit Q1 2021 · Mar 31, 2020 $1.5M
Revenue Q1 2021 · Mar 31, 2021 $3.22M
Revenue Q1 2021 · Mar 31, 2020 $2.79M
Long Term Debt Q1 2021 · Dec 31, 2020 $9.17M